StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Portola Pharmaceuticals (PTLA) PT Raised to $50 at Citi
March 4, 2019 6:58 AM
Citi analyst Yigal Nochomovitz raised the price target on Portola Pharmaceuticals (NASDAQ: PTLA) to $50.00 (from $49.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Portola Pharmaceuticals (PTLA) PT Raised to $35 at Credit Suisse
March 4, 2019 8:30 AM
Pre-Open Stock Movers 03/01: (PBYI) (GPS) (ZS) Higher; (IMGN) (NTNX) (TSLA) Lower (more...)
March 1, 2019 9:23 AM
Portola Pharma (PTLA) Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
March 1, 2019 8:08 AM
Portola Pharma (PTLA) Misses Q4 EPS by 23c
March 1, 2019 8:08 AM
Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
March 1, 2019 8:05 AM
Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
March 1, 2019 8:03 AM
Portola Pharma (PTLA) Announces European CHMP Adopts Positive Opinion on Ondexxya
March 1, 2019 7:39 AM
European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent
March 1, 2019 7:38 AM
